Real-world evidence for meningococcal B vaccines and how to have MenB conversations in general practice

Description

In this Product Explainer, Paediatrician and Paediatric Immunologist Prof Peter Richmond explains how Meningococcal serogroup B (MenB) disease remains the most common cause of IMD in children, adolescents and young adults, and provides an overview of the real-world evidence for MenB vaccines, and conversation strategies for use with families in general practice (6 mins).

Icon 2

NEXT LIVE Webcast

:
Days
:
Hours
:
Minutes
Seconds
Dr Gabby Mahoney

Dr Gabby Mahoney

Eczema Management Practical Tips

Prof Deborah Bateson

Prof Deborah Bateson

Oral Contraception Updates

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Prof Genie Pedagogos, Prof Richard MacIsaac & A/Prof Ralph Audehm

Panel Discussion on GLP1s for Chronic Kidney Disease in Type 2 Diabetes

Prof Clara Chow AM

Prof Clara Chow AM

COVID and the Heart – Short & Long-Term Impacts and Risks

Join us for the next free webcast for GPs and healthcare professionals

High quality lectures delivered by leading independent experts

Prof Peter Richmond

expert

Prof Peter Richmond

Consultant Paediatric Immunologist & Paediatrician, Perth Children’s Hospital. Head, Department of Immunology, Child & Adolescent Health Service WA. Director, Vaccine Trials Group, Wesfarmers Centre of Vaccines & Infectious Diseases, The Kids Research Institute Australia.

Date published: 21 June 2022